IL10 and colitis: For example, a Lactococcus lactis strain secreting IL-10 was found to decrease DSS-induced colitis by 50%; however, humans treated with a biocontained strain (thyA-/hIL-10+) did not experience beneficial effects in a phase II-A trial (Steidler et al., 2000, 2003, 2009).